GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman & CEO, David Dodd, will present at NobleCon20 - the Noble ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback